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Background: The excess risk of violence in psychotic disorders may partly be explained by impairments in ex-
ecutive functions (EFs) and theory of mind (ToM). However, previous studies have been limited by composite
measures of EFs and small samples of inpatients.
Methods: Data were collected for the research project Genetic Risk and Outcome of Psychosis (GROUP). Patients
with psychotic disorders (N=891) were recruited from various care settings in the Netherlands. The following
neuropsychological tests were administered (targeted cognitive function in parentheses): (i) Continuous
Performance Test-HQ (inhibition); (ii) Response Shifting Task (cognitive flexibility); (iii) Wechsler Adult
Intelligence Scale, Third Edition (WAIS-III) Block Design subtest (fluid intelligence); (iv) Neuropsychological
Assessment Battery (NAB) Mazes Test (planning); (v) Degraded Facial Affect Recognition Task (affective ToM);
and (vi) Hinting Task (cognitive ToM). Lifetime violence was ascertained from medical records and patient
interviews. We used analysis of covariance to compare the mean scores of violent and nonviolent patients on
each test, adjusting for age and sex.
Results: Violent patients performed significantly worse than nonviolent patients on the WAIS-III Block Design
subtest (F [1, 847]= 5.12, p= .024), NAB Mazes Test (F [1, 499]= 5.32, p= .022) and Hinting Task (F [1,
839]=9.38, p= .002). For the other tests, the between-group differences were nonsignificant. Violent behavior
explained no more than 1% of the variance in performance on each test.
Conclusion: Impairments in EFs and ToM are unlikely to provide useful targets for risk assessment and inter-
ventions.
1. Introduction
People with psychotic disorders are at increased risk of violent be-
havior compared with the general population (Fazel et al., 2009; Large
and Nielssen, 2011). In a meta-analysis of 20 studies with a total of 18
423 cases and 1 714 904 unaffected controls, the odds ratio for violence
in schizophrenia was 5.5 (95% confidence interval [CI] 4.1–7.5) and in
other psychotic disorders 4.9 (95% CI 3.6–6.6)(Fazel et al., 2009). More
recent studies have confirmed this risk using family-based designs
(Fazel et al., 2014a; Sariaslan et al., 2016). Several risk factors for
violence in psychotic disorders have been identified, including previous
crime, symptoms of delusions and hallucinations, lack of insight and
substance misuse (Witt et al., 2013). Potentially important, but rarely
studied, are impairments in executive functions (EFs) and theory of
mind (ToM).
EFs are mental operations needed to direct behavior toward the
realization of goals (Miller and Wallis, 2009). There are three ele-
mentary EFs: inhibition, working memory and cognitive flexibility.
These combine to build the higher order EFs of fluid intelligence (i.e.
reasoning and problem solving) and planning (Diamond, 2013). ToM is
the ability to infer mental states (e.g. motivations, emotions) in oneself
and others (Fonagy and Allison, 2012). Two types of ToM can be dis-
tinguished, according to whether the mental state being inferred is af-
fective (i.e. affective ToM) or cognitive (i.e. cognitive ToM) in nature
(Shamay-Tsoory et al., 2010).
Since EFs and ToM are essential for social adaptation, impairments
in these cognitive functions are thought to underlie violent behavior.
However, causal mechanisms likely differ by EF (Raine, 2008) and ToM
type (Adshead et al., 2013). General population studies have repeatedly
found that people who display violent behavior perform worse on
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neuropsychological tests of EFs (Ogilvie et al., 2011) and ToM (Hoaken
et al., 2007; Nyline et al., 2018) than those who do not. A meta-analysis
of 126 studies totaling 14 786 participants reported a significant inverse
association between test performance and antisocial behavior (in-
cluding violence) across EFs. This association had a medium effect size
(d=0.4, 95% CI 0.4–0.5) (Ogilvie et al., 2011).
Impairments in EFs and ToM are a core feature of psychotic dis-
orders (Kahn and Keefe, 2013). An umbrella review of 10 meta-analyses
found that individuals with schizophrenia performed between 0.5 and
1.5 standard deviations below unaffected controls on tests of EFs
(Reichenberg and Harvey, 2007). Meta-analyses of ToM have reported
similar effect sizes (Chung et al., 2014; Sprong et al., 2007). By and
large, EF and ToM deficits are present before illness onset (Kahn and
Keefe, 2013), stable over time (Reichenberg, 2011) and independent of
psychotic symptoms (Nieuwenstein et al., 2001) and treatment with
antipsychotic medication (Mishara and Goldberg, 2004). Furthermore,
they are associated with adverse outcomes such as rehospitalization
(Harvey et al., 2013), substance misuse (Eack et al., 2015) and low
educational attainment (Keefe, 2008).
Based on this, it may be hypothesized that EF and ToM impairments
partly explain the excess risk of violent behavior in psychotic disorders.
The few studies investigating this hypothesis have produced mixed
results for EFs (Barkataki et al., 2005; Fullam and Dolan, 2008; Lapierre
et al., 1995; Krakowski et al., 2016; Serper et al., 2008) and affective
ToM (Abu-Akel and Abushua'leh, 2004; Frommann et al., 2013; Silver
et al., 2005; Weiss et al., 2006). However, these studies were limited by
small samples of male inpatients or prisoners, a single data source of
violent behavior and composite measures of EFs. To our knowledge,
there has only been one study of cognitive ToM. This study reported a
significant association between higher scores on the Unexpected
Transfer Task (Perner and Wimmer, 1985) and lifetime violence (re-
lative risk= 1.2, p < .05), ascertained from medical records and in-
terviews with hospital staff, in patients with schizophrenia. This finding
may be attributed to selection bias: the sample size was small (N=24),
and the violent patients were recruited from a high-security psychiatric
hospital (Abu-Akel and Abushua'leh, 2004).
To address the limitations of previous studies, we have investigated
the association between neuropsychological test performance and a
sensitive marker of violent behavior for a comprehensive set of EFs and
affective and cognitive ToM in a large nationwide sample of people
with psychotic disorders.
2. Methods
2.1. Setting and participants
Data (release 5.0) were collected as part of a larger project, called
Genetic Risk and Outcome in Psychosis (GROUP). GROUP is conducted
by the psychiatry departments of 4 university medical centers (i.e.
Amsterdam Medical Center, Maastricht University Medical Center+,
University Medical Center Groningen, University Medical Center
Utrecht) and their affiliated mental health centers (k=36) in the
Netherlands. Together, these centers provide access to inpatient or
outpatient treatment to approximately 75% of the Dutch population.
Assessments took place at baseline (2004) and after three and six years
of follow-up. Eligible patients were identified by screening clinicians'
caseloads for the following criteria: (i) age between 16 and 50; (ii) good
command of the Dutch language; and (iii) Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
(American Psychiatric Association, 2000) diagnosis of schizophrenia or
another psychotic disorder. There were no exclusion criteria. The pro-
tocol was approved centrally by the ethics committee of the University
Medical Center Utrecht, and all patients gave written informed consent
before the first assessment.
2.2. Measures
The psychometric properties of the instruments and training of re-
search personnel have been described elsewhere (Korver et al., 2012).
2.2.1. Neuropsychological tests
We chose tests whose targeted cognitive functions (in parentheses)
are hypothetically related to violent behavior: (i) Continuous
Performance Test-HQ (CPT-HQ) (Nuechterlein and Dawson, 1984)
(inhibition); (ii) Response Shifting Task (RST) (Bilder et al., 1992)
(cognitive flexibility); (iii) Wechsler Adult Intelligence Scale, Third
Edition (WAIS-III) (Wechsler, 1997) Block Design subtest (fluid in-
telligence); (iv) Neuropsychological Assessment Battery (NAB) (Stern
and White, 2003) Mazes Test (planning); (v) Degraded Facial Affect
Recognition Task (DFAR) (van't Wout et al., 2004) (affective ToM); and
(vi) Hinting Task (Corcoran et al., 1995) (cognitive ToM). The NAB
Mazes Test was only administered at the third wave. Information about
the testing procedure can be found in the supplement.
2.2.2. Symptom severity Singh et al., 2011
Symptom severity was measured with the Positive and Negative
Syndrome Scale (PANSS) (Kay et al., 1987).
2.2.3. Substance misuse
The Substance Abuse Module of the Composite International
Diagnostic Interview (World Health Organization, 1990) was used to
establish a lifetime history of substance misuse. We defined alcohol
misuse as an average intake of more than 18 standard drinks per week
for men and more than 12 standard drinks per week for women during a
minimum period of 2 weeks in the past year or 4 weeks at any other
point in the past. These cutoffs reflect the median of several national
guidelines and a consistent 1.5:1 male to female consumption ratio
(Furtwaengler and de Visser, 2013). For other substances, misuse re-
ferred to a DSM-IV-TR diagnosis of abuse or dependence.
2.2.4. Violent behavior
Violent behavior, defined as the use of physical force with the in-
tention to harm another person, was assessed with the Life Chart
Schedule (LCS) (Susser et al., 2000). The reference period was the
lifetime. The LCS was filled out based on review of medical records and
interviews with the patient and, if possible, one or both parents.
2.3. Statistical analysis
In the analyses involving the NAB Mazes Test, we used age, PANSS
total score and educational level at the third wave. Otherwise, baseline
data were used. Higher scores on all tests reflected better performance,
apart from certain subscales of the CPT-HQ (i.e. number of commission
errors) and RST (i.e. accuracy cost, reaction time cost). Therefore, these
scores were reversed for the current analyses. For the CPT-HQ and RST,
we created composite scores by transforming the scores on the sub-
scales to z-scores and then averaging the z-scores. This method for
creating composite scores is widely used (Harrison et al., 2016;
Mancuso et al., 2011). To reduce confounding by impairments in face
recognition ability, patients with scores below 18 on the Benton Facial
Recognition Test (Benton et al., 1983) were excluded from the analyses
with the DFAR.
Depending on the scale of measurement, we assessed differences
between violent and nonviolent patients on descriptive characteristics
with the χ2-test (nominal) or t-test (continuous). Analysis of covariance
(ANCOVA) was used to compare the mean scores of violent and non-
violent patients on each neuropsychological test. For theoretical rea-
sons, we included age (Henry et al., 2013) and sex (Longenecker et al.,
2010) as covariates. We only analysed patients with available data on
all model variables. This reduced the total number of patients from 1
013 to 891.
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To evaluate the robustness of the results, we repeated the analyses
after separately removing: (i) patients whose violence did not result in
injury; (ii) patients who had been violent before illness onset; (iii) pa-
tients with PANSS total scores of 95 or higher, indicative of “marked or
severe illness” (Leucht et al., 2005); (iv) patients who had misused
substances; and (v) patients who had not completed secondary educa-
tion.
All models satisfied the assumptions of ANCOVA (e.g. homo-
scedasticity, homogeneity of regression slopes). The level of statistical
significance was set at 5%. Analyses were carried out in SPSS 21.0.
3. Results
Table 1 shows the demographic and clinical characteristics of the
patients (N=891) at baseline. The mean age was 27.2 (SD=7.0).
Most patients were male (n=688, 77%) and had received a diagnosis
of schizophrenia (n=615, 69%). The prevalence of violent behavior
was 21% (n=183). Violent patients were significantly younger (t
[889]=2.9, p= .004), had higher PANSS total scores (t [809]= 3.80,
p< .001) and were more likely to have misused substances (χ2
[1]= 4.26, p= .039) than nonviolent patients.
Violent patients performed worse than nonviolent patients on most
neuropsychological tests (Table 2). On average, they had fewer hits and
longer reaction times for hits on the CPT-HQ, higher accuracy and re-
action time cost scores on the RST and lower scores on the WAIS-III
Block Design subtest, NAB Mazes Test and Hinting Task. The mean
number of commission errors on the CPT-HQ was lower and the per-
centage of correctly identified emotions on the DFAR was higher in
violent patients, indicating better performance. The between-group
differences reached statistical significance for the WAIS-III Block Design
subtest (F [1, 847]= 5.1, p= .024), NAB Mazes Test (F [1,
499]= 5.32, p= .022) and Hinting Task (F [1, 839]=9.4, p= .002).
Effect sizes were small: violent behavior explained 1% or less of the
variance in performance on each test.
We observed no material differences in results when restricting the
analyses to patients whose violence resulted in injury (Table S2), pa-
tients who had only been violent after illness onset (Table S3), patients
with PANSS total scores below 95 (Table S4), patients without sub-
stance misuse (Table S5) or patients who had completed secondary
education (Table S6).
4. Discussion
In a nationwide sample of 891 patients with psychotic disorders, we
have investigated the association between neuropsychological test
performance and lifetime violence for a comprehensive range of ex-
ecutive functions and affective and cognitive theory of mind. Violent
patients performed significantly worse than nonviolent patients on tests
of fluid intelligence (i.e. WAIS-III Block Design subtest), planning (i.e.
NAB Mazes Test) and cognitive ToM (i.e. Hinting Task). However, effect
sizes were small.
Violent behavior in people with impaired fluid intelligence may be a
maladaptive solution to (Weiss, 2012) or consequence of increased
stress responsivity in provocative situations (Sandi and Haller, 2015).
Planning deficiencies increase the probability of violence by negatively
affecting a person's ability to assess the possible consequences of his or
her actions (Meijers et al., 2017). Impairments in ToM may lead to
violence through misinterpretation of social cues (Adshead et al.,
2013), underregulation of negative emotions (Fonagy and Luyten,
2009), blurring of self-other boundaries (Adshead et al., 2013) or lack
of empathy (Hooker et al., 2008). There was no significant difference
between violent and nonviolent patients in affective ToM, which is
arguably more important for the last three than cognitive ToM. This
lends weight to misinterpretation of social cues – insofar they relate to
other people's cognitive mental states – as a reason for violent behavior
in psychotic disorders. Cognitive ToM also subserves insight (Ng et al.,
2015) and, relatedly, treatment adherence (Shad et al., 2006). Insight
refers to a person's acknowledgement of having an illness that requires
treatment (Beck et al., 2004). A person lacking insight may not seek or
adhere to treatment, thereby allowing psychotic symptoms to persist or
worsen (Higashi et al., 2013). Furthermore, a strong conviction that
delusions or hallucinations are real may bring a person to act on them
(Bjørkly, 2006). Alternative explanations for the findings are con-
founding by biological (e.g. genetics, neurobiological abnormalities) or
early environmental (e.g. poor nutrition, maltreatment) risk factors
(Lamsma and Harte, 2015).
There are several limitations to this study. First, causality cannot be
inferred because violent behavior preceded test administration by a
potentially long period of time. However, the relative stability of cog-
nition makes this less problematic. Second, the LCS does not distinguish
between community and inpatient violence, which may have different
cognitive correlates (Weiss, 2012). It has also been suggested that
cognitive impairment is more pronounced in patients who persistently
display violent behavior from an early age than in those who become
violent after illness onset (Hodgins and Klein, 2017). However, we
found similar results in the latter. Third, most patients had used anti-
psychotic medication. This may have attenuated associations, as some
antipsychotics – most notably clozapine – have been shown to reduce
Table 1
Baseline characteristics of patients with psychotic disorders.
Violent behavior
Yes (n=183) No (n=708) Test statistic (df) p
Demographic characteristics
Age, mean (SD) in years 25.9 (6.3) 27.6 (7.2) t (889)=2.9 .004
Male, n (%) 145 (79) 543 (77) χ2 (1)= 0.53 ns
Caucasian. n (%) 137 (76) 559 (80) χ2 (8)= 9.66 ns
Completed secondary education, n (%) 146 (80) 620 (88) χ2 (1)= 8.17 .004
Clinical characteristics
DSM-IV-TR diagnosis χ2 (3)= 6.80 ns
Schizophrenia, n (%) 136 (74) 479 (68)
Schizoaffective disorder, n (%) 18 (10) 90 (13)
Psychotic disorder NOS, n (%) 18 (10) 57 (8)
Other, n (%) 11 (6) 82 (12)
Age of onset, mean (SD) in years 21.7 (5.6) 23.4 (6.6) t (889)=3.37 .001
PANSS total score (SD) 58.9 (17.1) 53.5 (16.2) t (809)=3.80 < .001
Substance misuse, n (%) 118 (68) 405 (60) χ2 (1)= 4.26 .039
df, degrees of freedom; SD, standard deviation; ns, nonsignificant; DSM-IV-TR, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision;
NOS, not otherwise specified; PANSS, Positive and Negative Syndrome Scale.
Due to missing data, the total number of patients varies per characteristic.
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violence (Bhavsar et al., 2019; Fazel et al., 2014b). However, reported
improvements in EFs (Mishara and Goldberg, 2004) and ToM
(Kucharska-Pietura and Mortimer, 2013) after treatment with anti-
psychotics are usually too small to be considered clinically significant.
For that reason, we expect attenuation to have been negligible. Fourth,
neuropsychological tests have limited construct and ecological validity.
The construct validity, or the degree to which an instrument measures
what it is designed to measure, of many tests is lowered by systematic
variance in performance that is attributable to nontargeted cognitive
functions. For example, the WAIS-III Block Design subtest not only
measures fluid intelligence but also visual-spatial skills (Lera-Miguel
et al., 2011). Ecological validity concerns the extent to which the score
obtained with an instrument can be generalized to real-world settings
(Dawson and Marcotte, 2017). An individual who performs at or above
the normative level on a test may still experience difficulties in ev-
eryday life when requiring the cognitive function targeted by that test.
For one reason, the demands placed on cognitive functions in real-
world settings are more complex than in experimental settings. For
another, neuropsychological tests are designed to detect clinically sig-
nificant impairments in cognitive functions. This is relevant, as cogni-
tive impairments in violent individuals are often subclinical (Ogilvie
et al., 2011). Fifth, cognitive ToM was assessed verbally. Given that
poverty of speech is a prominent symptom of psychotic disorders, this
may have introduced bias (Sarfati et al., 1999). However, a meta-ana-
lysis of 29 studies found that individuals with schizophrenia (N=1
518) performed similarly on verbal (d=1.2, 95% CI 1.0–1.5) and
nonverbal (d=1.3, 95% CI 1.0–1.5) tests of cognitive ToM (Sprong
et al., 2007). Finally, the CPT-HQ measures only one of three types of
inhibition, namely selective attention. The other types are cognitive
inhibition and self-control. Selective attention allows one to focus on a
particular stimulus, while ignoring others. Cognitive inhibition involves
the suppression of irrelevant thoughts, typically to support working
memory. Self-control refers to goal-oriented regulation of thoughts and
emotions (Diamond, 2013). As such, self-control may be expected to be
most directly related to violent behavior. However, selective attention
and self-control are highly correlated (Friedman and Miyake, 2004) and
recruit largely the same neural systems (Cohen et al., 2006).
The findings of this study provide little justification for using EFs
and ToM as targets for risk assessment and interventions. While most
risk assessment tools do not contain items for cognitive functions (Singh
et al., 2011), the small effect sizes suggest that additional items for fluid
intelligence, planning and cognitive ToM would confer marginal im-
provements at most. For the same reason, interventions aimed at im-
proving fluid intelligence, planning and cognitive ToM are unlikely to
prevent violent behavior on their own. To improve understanding of
causal mechanisms, future studies should use prospective designs and
test for additional confounders and mediators.
In conclusion, we have found significant but small associations be-
tween poorer neuropsychological test performance and violent beha-
vior in psychotic disorders for three cognitive functions: fluid in-
telligence, planning and cognitive ToM. This provides some empirical
support for cognitive models of violent behavior. At the same time, the
findings suggest that impairments in EFs and ToM have little to no
value for risk assessment and interventions.
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